UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 187 filers reported holding UNIQURE NV in Q4 2019. The put-call ratio across all filers is 0.31 and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $243,000 | -76.7% | 7,349 | -78.2% | 0.00% | -50.0% |
| Q2 2021 | $1,041,000 | -6.8% | 33,692 | +1.9% | 0.00% | -33.3% |
| Q1 2021 | $1,117,000 | +59.3% | 33,068 | +70.9% | 0.00% | +50.0% |
| Q4 2020 | $701,000 | -2.0% | 19,352 | -0.1% | 0.00% | 0.0% |
| Q3 2020 | $715,000 | -16.2% | 19,371 | +2.3% | 0.00% | -33.3% |
| Q2 2020 | $853,000 | -19.9% | 18,934 | -15.6% | 0.00% | -25.0% |
| Q1 2020 | $1,065,000 | -11.2% | 22,444 | +34.1% | 0.00% | 0.0% |
| Q4 2019 | $1,199,000 | +3325.7% | 16,735 | +2712.6% | 0.00% | – |
| Q1 2019 | $35,000 | +483.3% | 595 | +288.9% | 0.00% | – |
| Q2 2018 | $6,000 | +50.0% | 153 | 0.0% | 0.00% | – |
| Q1 2018 | $4,000 | – | 153 | +7550.0% | 0.00% | – |
| Q2 2017 | $0 | – | 2 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
| Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
| 683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
| PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
| Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
| Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
| Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
| Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
| Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |